Stay updated on Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.

Latest updates to the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page
- Check3 days agoChange DetectedThe record now presents details of the completed OTL-101 gene-therapy study for ADA-SCID, including its eligibility criteria, treatment plan, outcome measures, and study dates.SummaryDifference47%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page otherwise remains a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study content. This prevents viewing the study details on that record.SummaryDifference18%

Stay in the know with updates to Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.